Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This paper describes a method for dissociation of intrinsic neurones from the atria and interatrial septum of newborn guinea-pig heart and their maintenance in culture. The appearance of the cultured intracardiac neurones, muscle and other non-neuronal cell types also present in the preparation has been observed by phase-contrast microscopy. Some of the neurochemical properties of the intracardiac neurones in culture have been investigated using histochemical methods. All the neurones studied were shown to contain
acetylcholinesterase
. No catecholamine-containing neurones were found. Using an indirect immunofluorescence technique, 20-50% of clearly identifiable neurones in culture contained neuropeptide Y-like immunoreactivity.
Vasoactive intestinal polypeptide
-like immunoreactive neurones were found in only one out of 15 culture preparations; no substance P-, neurotensin-, or enkephalin-like immunoreactivity was observed. These findings are consistent with those described for intracardiac neurones studied in situ, suggesting that the neurochemical differentiation of the intrinsic heart neurones is retained in culture. The culture preparation provides an opportunity to study the properties and role of intrinsic neurones of the heart. The characteristics of the intracardiac neurones may be distinguished from those of the extrinsic nerve fibres which degenerate in culture. Further, the intracardiac neurones are more accessible to experimental manipulation in culture than in situ.
...
PMID:Intrinsic neurones and associated cells of the guinea-pig heart in culture. 394 57
Numerous nerve fibres containing
vasoactive intestinal peptide (VIP)
, substance P (SP) or immunoreactive avian pancreatic polypeptide (APP) occur in the nasal mucosa of several mammals, including man. Generally, the nerve fibres are distributed around small blood vessels and seromucous glands. In addition, SP containing fibres can be seen in the nasal epithelium. The pterygopalatine ganglion contains
acetylcholinesterase
(
AChE
) positive nerve cell bodies together with VIP and SP containing ones. After exposure to colchicine it could be shown that the VIP and SP containing nerve cell bodies also were positive for
AChE
. VIP and SP are potant mediators of atropine resistent vasodilatation in the mucosa. The physiological effects of APP are not known.
...
PMID:Peptide containing nerves in the nasal mucosa. 616 79
Four peptides--vasoactive intestinal polypeptide, substance P, somatostatin and a peptide-like avian pancreatic polypeptide--have been found in nerves of the human male genitalia using highly sensitive and specific methods of immunocytochemistry and radioimmunoassay. Five other peptides (met-enkephalin, leu-enkephalin, neurotensin, bombesin and cholecystokinin-8) were absent.
Vasoactive intestinal polypeptide
was the most abundant peptide, its highest concentration being in the proximal corpus cavernosum. Immunoelectron microscopy localized this peptide to large (97 +/- 20 nm), round, electron-dense granules of p-type nerve terminals.
Vasoactive intestinal polypeptide
-immunoreactive neuronal cell bodies were found in the prostate gland and the root of the corpus cavernosum. Substance P immunoreactive material was present in smaller concentration and was mainly localized in nerves around the corpuscular receptors of the glans penis. Somatostatin immunoreactive nerves were associated mainly with the smooth muscle of the seminal vesicle and the vas deferens. When antiserum to avian pancreatic polypeptide was applied, certain nerves were stained, particularly in the vas deferens, the prostate gland and the seminal vesicle. However, chromatography detected no pure avian pancreatic polypeptide suggesting the presence of a structurally related substance, possibly neuropeptide Y, which cross-reacts with the avian pancreatic polypeptide antiserum. Similar distributions between vasoactive intestinal polypeptide-immunoreactive and
acetylcholinesterase
-positive nerves and between avian pancreatic polypeptide-immunoreactive and adrenergic nerves were observed. A general neuronal marker, neuron-specific enolase, was used to investigate the general pattern of the organ's innervation. The abundance and distribution patterns of these peptide-immunoreactive nerves indicate that they may play important roles in the male sexual physiology.
...
PMID:Peptidergic innervation of the human male genital tract. 619 58
Vasoactive intestinal polypeptide
(
VIP
)- and substance P-containing nerve fibers were observed in the cerebral blood vessels using an immunohistochemical technique.
VIP
-containing nerve fibers distributed in a spiral pattern, similar to that of muscle cells. Under electron microscopic observation,
VIP
-immunoreactive terminals lay close to a muscle cell in the inner layer of the adventitia. In contrast, substance P-containing nerve fibers showed a meshwork pattern in the outer layer of the adventitia. Using both
acetylcholinesterase
(
AChE
) staining and
VIP
immunohistochemistry,
AChE
-positive and
VIP
-immunoreactive nerve fibers revealed almost the same distribution in the same specimen. The present data suggest that
VIP
-containing nerve fibers may play a role in the smooth muscle control of the blood vessels, whereas substance P-containing nerve fibers may not take part in muscle control.
...
PMID:A light and electron microscopic immunohistochemical study of vasoactive intestinal polypeptide- and substance P-containing nerve fibers along the cerebral blood vessels: comparison with aminergic and cholinergic nerve fibers. 620 80
Addition of
vasoactive intestinal peptide (VIP)
to brain homogenates increased the activity of choline acetyltransferase (ChAT) but not that of
acetylcholinesterase
or glucose-6-phosphate dehydrogenase. Activity of ChAT was increased in the anterior hypothalamus and in the dorsal and ventral hippocampus, but not in the parietal cortex or posterior hypothalamus. Increased activity occurred rapidly after VIP addition to homogenates and was maximal at 10(-7)M concentration. Kinetic analysis indicates that the Vmax of the enzyme is increased and the Km for choline, but not acetyl-coenzyme A, is decreased in the presence of VIP. Results support a possible VIP-cholinergic interaction in the CNS.
...
PMID:Activation of choline acetyltransferase by vasoactive intestinal peptide. 632 60
Previous studies of the development of cholinergic sympathetic innervation of sweat glands in rat footpads suggested that these terminals initially exhibit noradrenergic properties which are lost as the glands and their innervation mature. We have treated neonatal and adult rats with 6-hydroxydopamine (6-OHDA), a toxic congener of norepinephrine, and compared its effects on the cholinergic sympathetic innervation of sweat glands and the noradrenergic sympathetic innervation of the iris, salivary gland, and blood vessels. As reported by others, 6-OHDA treatment of neonates caused the destruction of noradrenergic fibers in the iris and salivary gland but did not affect other fibers projecting to these targets that stain for
acetylcholinesterase
(
AChE
). We found that 6-OHDA treatment of neonatal animals also caused the destruction of the sympathetic axons in immature sweat glands that possess catecholamine histofluorescence and tyrosine-hydroxylase-like immunoreactivity. Furthermore, when such animals were examined as adults, we found no
AChE
staining,
vasoactive intestinal peptide (VIP)
-like immunoreactivity, or characteristic sympathetic axonal varicosities. However, the denervated glands were invested by a plexus of sensory axons, some of which exhibited substance P-like immunoreactivity (SP-IR). An increase in the number of SP-IR fibers also occurred in the sympathetically denervated irides of these animals. Chronic treatment of neonates with guanethidine, another adrenergic sympathetic neurotoxin, resulted in similar loss of cholinergic sweat gland innervation. Treatment of adults rats with doses of 6-OHDA identical to those used to treat neonates caused the loss of noradrenergic fibers from the iris, salivary gland, and many blood vessels but did not noticeably affect
AChE
and VIP staining or axonal ultrastructure in the sweat glands. However, treatment with higher doses of 6-OHDA did cause significant axonal degeneration. The response of the sympathetic innervation of developing but not mature sweat glands to 6-OHDA provides evidence for a transition from noradrenergic to cholinergic phenotype during the development of sympathetic neurons in vivo similar to the transition observed in cell culture. The sprouting of sensory axons may be caused by NGF-like trophic influences present in some sympathetically denervated tissues.
...
PMID:Neonatal 6-hydroxydopamine treatment eliminates cholinergic sympathetic innervation and induces sensory sprouting in rat sweat glands. 642 23
Most principal neurons in sympathetic ganglia are noradrenergic. A small population, especially those that innervate sweat glands in rat footpads, are cholinergic. We have characterized the innervation of the glands in adult and developing rats to determine whether sympathetic neurons undergo a transition from noradrenergic to cholinergic during normal development as has been observed in culture. In adult rats, the fibers innervating sweat glands exhibited strong
acetylcholinesterase
(
AChE
) staining and
vasoactive intestinal peptide (VIP)
-like immunoreactivity. None of the axons contained endogenous catecholamines detectable with formaldehyde-induced fluorescence or permanganate fixation. However, like cholinergic sympathetic neurons in culture, all axons could take up and store exogenous catecholamine. The sweat glands and their innervation develop postnatally. At 7 days, the axons innervating sweat glands possessed endogenous catecholamine histofluorescence and small granular vesicles but not
AChE
or VIP. By 14 days,
AChE
and VIP staining was pronounced. In contrast, catecholamine fluorescence and the number of small granular vesicles were reduced, and by 21 days they were absent. Further, neonatal treatment with 6-hydroxydopamine, a toxic norepinephrine congener, resulted in the loss of cholinergic as well as noradrenergic sympathetic innervation. These observations are consistent with a transition from noradrenergic to cholinergic function in vivo.
...
PMID:Development of cholinergic sympathetic neurons: evidence for transmitter plasticity in vivo. 683 80
The release of
vasoactive intestinal peptide (VIP)
from the canine gut and its possible neural origin were studied using two agents, oxytocin and neostigmine, known to increase peripheral levels of VIP. Oxytocin and neostigmine increased the portal concentrations of VIP by threefold and sevenfold, respectively. A considerable portal/femoral vein gradient ranging from twofold in the basal state to sevenfold during stimulation with neostigmine indicated that the gut was the main source of circulating VIP. The contribution of the brain was minor, and that of the uterus was undetectable. Release of VIP occurred from the entire gut: After enterectomy, the residual gut (stomach, pancreas, and proximal duodenum) released spontaneously a large amount of VIP which masked the effect of oxytocin. Tetrodotoxin and hexamethonium, but not atropine, inhibited oxytocin-stimulted release of VIP by 80% and 60% respectively. This prompted the conclusion that the release of VIP was predominantly neurally mediated and that the chain of transmission involved a preganglionic cholinergic pathway. Hexamethonium strongly inhibited neostigmine-stimulated release of VIP. Atropine was even more potent in that it abolished the effect of neostigmine. The effect of atropine was attributed to a blockade of ganglionic muscarinic receptors, which are preferentially activated by
cholinesterase
inhibitors like neostigmine. The results of this study and those derived from electrical stimulation of the vagus nerve are consistent with the hypothesis that circulating VIP is released from intrinsic neurons of the gut under preganglionic cholinergic control.
...
PMID:Neural release of vasoactive intestinal peptide from the gut. 743 34
The peptidergic innervation of the human superficial temporal artery was investigated by means of immunohistochemical, ultrastructural, and in vitro pharmacological techniques. A dense network of nerve fibers was found in the adventitia. The majority of the nerve fibers displayed immunoreactivity for tyrosine hydroxylase and neuropeptide Y (NPY). A moderate supply of perivascular nerve fibers displayed either
acetylcholinesterase
activity or immunoreactivity for
vasoactive intestinal peptide (VIP)
, peptide histidine methionine-27 (PHM), and calcitonin gene-related peptide (CGRP). Only a few nerve fibers displayed substance P (SP), neurokinin A (NKA), and neuropeptide K (NPK) immunoreactivity. In double immunostained preparations, SP immunoreactivity was co-localized with NPK and CGRP in the same nerve fibers. Ultrastructural studies revealed the presence of numerous axon variocosities at the adventitial--medial border. NPY, VIP, and CGRP immunoreactivities occurred in the same type of large granular vesicles, but in morphological distinct nerve profiles. NPY had, in general, no direct vasoconstrictor effect. However, at a low concentration of NPY contractile response induced by NA (10(-7)-10(-6)M) was 9-15 times enhanced. The NPY-induced potentiation of the NA-induced contraction was not dependent on the presence of an intact endothelium. No significant difference was found between acetylcholine, VIP, and PHM in either potency or degree of relaxation. SP, NKA, and CGRP also acted as vasodilatory agents, with CGRP being more potent than the tachykinins. The response to SP, but not CGRP, was dependent on an intact endothelium. Pretreatment of the vessels with a low concentration of NPY did not change the responses to ACh, VIP, SP, or CGRP.
...
PMID:The peptidergic innervation of the human superficial temporal artery: immunohistochemistry, ultrastructure, and vasomotility. 754 Feb 93
We investigated the effects of an enteric infection with the parasitic nematode, Trichinella spiralis, on peptidergic and cholinergic neural pathways of the guinea pig jejunum. The content of the enteric neuropeptides, substance P (SP) and
vasoactive intestinal peptide (VIP)
, and the activities of the key cholinergic enzymes,
acetylcholinesterase
(
AChE
) and choline acetyltransferase (ChAT), were measured and compared in extracts of jejunal muscularis externa (ME) obtained from uninfected jejunum and T. spiralis-inflamed jejunum. Significant decreases were detected in both SP immunoreactivity and
AChE
activity on days 6 and 10 postinfection (PI) in nematode-infected guinea pig jejunum compared to uninfected controls. The maximum changes observed for SP and
AChE
both occurred on day 10 PI and were evident as decreases of 37% and 48%, respectively, from the mean uninfected control values for SP and
AChE
. In contrast, VIP immunoreactivity and ChAT activity showed no significant changes during the enteric phase of T. spiralis infection. Nematode-evoked histopathological changes in jejunal tissues from infected animals were associated with significant increases in myeloperoxidase (MPO) activity, an index of inflammation intensity, which occurred on day 6 PI (885% of mean control) and day 10 PI (469% of mean control) coinciding temporally with the significant decrease in SP content and
AChE
activity during infection. Thus, intestinal motor disturbances observed in mammalian hosts during enteric nematode infections involve inflammation-generated changes in the neurohumoral control of smooth muscle function.
...
PMID:Altered neuropeptide content and cholinergic enzymatic activity in the inflamed guinea pig jejunum during parasitism. 754 15
<< Previous
1
2
3
4
5
Next >>